The utilization of 1,3-butadiene as a modest and bountiful natural substance for new applications has drawn more interest in recent
"Allosteric modulators," a class of drugs that work at the M4 muscarinic receptor, a major target for notoriously difficult-to-treat psychiatric disorders associated with cognitive deficits, such as schizophrenia, have been